|
viewpoint
By: Paul S. Koch, M.D.
Who'll Pay for the Rx Drug Benefit?
August 2003
guest editorial
By: Ronald E. P. Frenkel, M.D., F.A.C.S., FICS
The Time is Right for the New Ocular Circulation Society and Journal
August 2003
at press time
The latest news
August 2003
asc management - Creating the ASC's Legal Structure
By: Larry E. Patterson, M.D.
We determine a legal structure for our ASC. The result is three interlocking entities.
August 2003
instrument insider
By: Roger Steinert, M.D.
The Diamond Knife Cleaning Pack from Rhein Medical, Inc.
August 2003
coding & reimbursement - Optical Claims: Avoiding Problems
By: Suzanne L. Corcoran, C.O.E.
Billing correctly for post-cataract eyeglasses isn't easy. Here are the pitfalls -- and how to avoid them.
August 2003
contact lens business - Choosing the Right Disposable
By: William Ehlers, M.D.
With more options available every year, these contact lenses offer something for almost everyone.
August 2003
marketing matters - LASIK Candidates: Go or No
By: Brad Ruden, M.B.A.
This practice has developed a clever and accurate way to determine who's suitable for surgery.
August 2003
rx perspective - Ocular Allergy: Upping the Ante
By: Steven J. Lichtenstien, M.D.
A higher concentration of olopatadine makes drops more effective and convenient -- with no apparent downside.
August 2003
spotlight on technology & technique - Beyond the Amsler Grid
By: Christopher Kent, Senior Associate Editor
An ingenious new instrument may detect CNV far earlier than the traditional test.
August 2003
marketplace
Focus on allergy medications; plus other new products and services
August 2003
New Avenues in Glaucoma Diagnostics
By: Christopher Kent, Senior Associate Editor
Ten specialists discuss the impact of the latest tools.
August 2003
Thinking of Going Digital?
By: Kathleen Salter, C.O.A.; Stewart A. Daniels, M.D.
This retinal practice tells how a well-planned switch to digital imaging can create numerous benefits.
August 2003
Cataract Surgery is About to Get Safer
Surgeons explain how they plan to use capsular tension rings once the FDA grants an approval.
August 2003
Capsule Rims: An Issue of Strength
By: Christopher Kent, Senior Associate Editor
A large plasma capsulotomy may be less likely to tear than a smaller capsulorhexis.
August 2003
stat tracker
The Latest Data on the Value of Goodwill
August 2003
Dear colleague,
By: Ivan Goldberg, M.D.
Dr. Goldberg's intro letter; Roundtable Panel
August 2003
Changing the Paradigm for Glaucoma DiagnosisChanging the Paradigm for Glaucoma Diagnosis
By: Robert N. Weinreb, M.D.
Find out why glaucoma diagnosis and management must encompass more than intraocular pressure and visual fields.
August 2003
The Impact of Progression on TreatmentThe Impact of Progression on Treatment
By: Paul P. Lee, M.D., J.D.
The answers to four key questions can have a big impact on treatment decisions. Learn the latest on recent trials and patient quality-of-life issues.
August 2003
The Cost Implications of "Lower is Better"The Cost Implications of "Lower is Better"
By: Leonard A. Levin, M.D., Ph.D.
Answering three vital questions about glaucoma treatment.Answering three vital questions about glaucoma treatment.
August 2003
IOL DESIGN: Looking Beyond the Edge
By: Samuel Masket, M.D.
The panel discusses three key aspects of intraocular lens design that have an impact on glare.
August 2003
ACHIEVING OPTIMAL VISION BY PREVENTING INFLAMMATION
By: Calvin Roberts, M.D.
NSAIDs are a valuable tool in preventing sight-diminishing inflammation after cataract surgery.
August 2003
Panelists
By: Robert N. Weinreb, M.D.; Robert J. Noecker, M.D., M.B.A.; Richard G. Fiscella, R.Ph., M.P.H.; Thomas K. Mundorf, M.D.; Scott A. Pastor, M.D.
August 2003
Generic vs. Branded Drugs: Understanding the Distinctions
Generic drugs can differ significantly from their branded counterparts. Here are some important points to consider.
August 2003
Understanding Bioequivalence
Here's a closer look at the FDA approval process for generic drugs.
August 2003
Generic Glaucoma Meds May Bring Surprises
Unreliable results or unwanted side effects may stem from poorly formulated suspensions/solutions or variations in bottle and drop sizes.
August 2003
Generic Brimonidine: Early Warning
We've seen that all generic ophthalmic products aren't necessarily safe, so be on guard for potential side effects.
August 2003
Dr. Slakter letter and Meet The Panel
By: Jason Slakter, M.D.
August 2003
Off the Charts
Our panel meets Alice and explores the risks of relying solely on visual acuity.
August 2003
Understanding the Patient's Problem
Here's what you should measure and why.
August 2003
Combining Forces
Retina and low-vision specialists work together to address patient expectations, lifestyle changes and depression.
August 2003
Charting New Territory
Our panel discusses how we can measure quality of vision.
August 2003
REFERENCES
August 2003
|
